<DOC>
	<DOCNO>NCT02684266</DOCNO>
	<brief_summary>SHR6390 small molecular , oral potent , selective CDK4/6 inhibitor . The purpose study investigate safety/tolerability pharmacokinetic profile SHR6390 Chinese advance solid tumor patient use `` 3+3 '' dose escalation.Preliminary efficacy also investigate study .</brief_summary>
	<brief_title>A Study SHR6390 Advanced Solid Tumor Patients</brief_title>
	<detailed_description />
	<criteria>Pathologically confirm solid tumor fail standard treatment Eastern Cooperative Oncology Group ( ECOG ) performance status : 01 Life expectancy ≥ 3 month Adequate function major organ , mean follow criterion meet within 14 day randomization : Hemoglobin &gt; 110g/L Neutrophils &gt; 2.0×10^9/L Platelets &gt; 100×10^9/L Total bilirubin &lt; 1.5×the upper limit normal ( ULN ) ALT AST ≤ 1.5×ULN ( ≤ 5×ULN , exist liver metastasis ) Creatinine ≤ 1 ULN Left ventricular ejection fraction ( LVEF ) ≥ 50 % QTcF ( Fridericia correction ) male≤450 m , female≤470 m Good compliance patient physician 's judgement Signed date informed consent Previously receive therapy antitumor agent target CDK4/6 Less 3 week last celltoxicity chemotherapy , less 6 week last mitomycin nitrosamine therapy Less 3 week antitumor therapy ( include target therapy , immunotherapy approve therapy ) Having join clinical trial within 4 week Uncontrolled/untreated brain metastasis ( wellcontrolled/welltreated brain metastasis physician 's judgement allow ) exist abnormal CTCAE≥grade 2 result previous treatment ( except grade 2 alopecia ) uncontrollable symptomatic pleural effusion ascites require clinical intervention require continous treatment steroid Factors influence usage oral administration ( e.g . unable swallow , chronic diarrhea intestinal obstruction , etc . ) exist uncontrollable hypokalemia hypomagnesemia history serious allergy event know allergy constitution active HBV HCV infection ( HBV virus≥10e4 copies/ml , HCV virus≥10e3 copies/ml ) History immunodeficiency , acquire congenital immunodeficiency , history organ transplantation history cardiac dysfunction , include ( 1 ) angina ( 2 ) clinical significant arrythmia require drug intervention ( 3 ) myocardial infarction ( 4 ) heart failure ( 5 ) cardiac dysfunction ( judged physician ) ; cardiac nephric abnormal ≥grade 2 find screen Female patient pregnancy , lactation woman childbearing potential test positive baseline pregnancy test childbearing female refuse accept contraception practice determine physician , coexist disease might lead life threaten complication avoid patient accomplish treatment ( e.g serious hypertension , diabetes , thyroid dysfunction , etc . ) history neuropathy dysphrenia , include epilepsy dementia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>neoplasm , Cycline-Dependent Kinase</keyword>
</DOC>